An Ongoing Phase 2 Study Of Hm15912, A Novel Long-Acting Glucagon-Like Peptide 2(Glp-2) Analog For Short Bowel Syndrome-Intestinal Failure (Sbs-If) Patients. (April 2023) - Kim, M.; Lee, W.; Cho, H.; Mroziak, B.; Joly, F.; Seo, J.-M.; Matysiak, K.; Maasberg, S.; Fusco, S.; Baek, S.; Iyer, K.